Atomoxetine in Melanocortin Obesity Syndrome

Clinical trial NCT06899178 · RECRUITING

Trial details

NCT number: NCT06899178
Sponsor: Icahn School of Medicine at Mount Sinai
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Melanocortin Obesity Syndrome MCOS

Start date: 2026-09-01
Primary completion: 2028-03-01
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.